Back Pain News and Research

Latest Back Pain News and Research

Positive results from Shire's velaglucerase alfa Phase III study for Type 1 Gaucher disease

Shire plc, the global specialty biopharmaceutical company, today presented positive results from its first Phase III study (TKT 032) evaluating safety and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy for the treatment of Type 1 Gaucher disease. The data were presented in an oral presentation at the Lysosomal Disease Network (LDN) World Symposium in Miami, Florida.

12 Feb 2010

Sales of Cobroxin exceeds XenaCare Holdings' projections for first 45 days of 2010

XenaCare Holdings, Inc., a company specializing in the marketing and retail distribution of consumer healthcare products, announced today that it has begun distributing and selling Cobroxin through mass food and drug retail chains in the Northeast, Southeast, Middle Atlantic and Midwest regions.

12 Feb 2010

Cognitive behavioral therapy effective for insomnia and chronic pain

Cognitive behavioral therapy for insomnia significantly improved sleep for patients with chronic neck or back pain and also reduced the extent to which pain interfered with their daily functioning, according to a study by University of Rochester Medical Center researchers.

11 Feb 2010

MHQP: Massachusetts primary care physicians achieve measurable improvements in health care quality

Massachusetts primary care physicians continue to achieve measurable improvements in important aspects of health care quality as reported by Massachusetts Health Quality Partners (MHQP). Today, the organization released its sixth annual Quality Insights: Clinical Quality in Primary Care report, comparing the performance of more than 150 medical groups across the state.

11 Feb 2010

MedX announces the completion of first sale in New Zealand

MedX Limited, the manufacturer and global distributor of MedX®-branded medical exercise and fitness equipment and a subsidiary of WellTek Incorporated, today announced the completion of its first sale in New Zealand, succeeding the sale of 227 MedX exercise and medical machines to customers in a diverse list of countries, including Australia, Germany, India, Scotland, South Korea, Spain and Switzerland.

11 Feb 2010

Acupuncture: An effective pain management therapy for pediatric patients

Doctors at Rush University Medical Center are offering pediatric patients diagnosed with chronic illnesses acupuncture therapy to help ease the pain and negative side effects like nausea, fatigue, and vomiting caused by chronic health conditions and intensive treatments.

10 Feb 2010

Doctors do not follow evidence-based guidelines for treating low back pain, says report

Australian general practitioners often treat patients with low back pain in a manner that does not appear to match the care endorsed by international clinical guidelines, according to a report in the February 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

9 Feb 2010

Hope for back pain: Minimally invasive facet arthrodesis and spinal cord stimulation

Results from the first prospective study of minimally invasive facet arthrodesis and long-term data on spinal cord stimulation demonstrate the viability of these options to achieve pain relief in patients with various back pain conditions. The studies were presented today at the American Academy of Pain Medicine's 26th Annual Meeting in San Antonio, TX.

5 Feb 2010

New research may help adopt acupuncture as a treatment option for NHS patients

Important new research about the effects of acupuncture on the brain may provide an understanding of the complex mechanisms of acupuncture and could lead to a wider acceptability of the treatment.

4 Feb 2010

Results from three phase two studies show the effectiveness of Tanezumab

Tanezumab, a humanized monoclonal antibody that targets nerve-growth factor, reduced pain in three common pain conditions, according to the results from three phase two studies presented today in a single poster at the American Academy of Pain Medicine's 26th Annual Meeting.

4 Feb 2010

Recent clinical trials in patients with ALBP show that SOMA 250 mg reduces disability

A recent analysis of two pivotal clinical trials in patients with acute low back pain (ALBP) who were treated with SOMA® (carisoprodol) 250 mg showed significantly improved functionality and reduced disability after three days of treatment, as measured by the Roland-Morris Disability Questionnaire (RMDQ).

4 Feb 2010

Study shows Cymbalta reduces chronic low back pain

In a new study, 60 mg of Cymbalta® (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared with placebo.

3 Feb 2010

AMPYRA for MS: Acorda Therapeutics announces wholesale pricing and patient assistance program

Acorda Therapeutics, Inc. today announced the wholesale acquisition cost (WAC) for AMPYRA™ (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.

3 Feb 2010

One-third of doctors and diabetes patients prioritize health conditions differently

About one-third of doctors and their patients with diabetes do not see eye to eye on the most important health conditions to manage, according to a survey by the University of Michigan Medical School.

3 Feb 2010

Sales of Nutra Pharma's Cobroxin totaled $583,955 for fourth-quarter ending December 31, 2009

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that sales of its recently launched over-the-counter pain reliever, Cobroxin, totaled $583,955 for the fourth quarter ending December 31, 2009.

3 Feb 2010

MISI opens new comprehensive spine care facility in Las Colinas

The Minimally Invasive Spine Institute, one of the most advanced diagnostic and treatment facilities for back and neck pain as well as spinal disorders in the United States, has opened a comprehensive spine care facility in Las Colinas to offer both holistic and traditional approaches to spine care, advancing physician practices by forever changing the patient experience.

2 Feb 2010

Millennials overly optimistic about their health despite unhealthy habits

According to Life University, a leading chiropractic college and vital health university, Millennials (ages 15-27), are overly optimistic about their own health, despite admitting to the same unhealthy habits that have caused chronic illness in previous generations.

2 Feb 2010

Cardiac catheterization: A groundbreaking tool in the field of cardiology

Cardiac catheterizations have been a groundbreaking tool in the field of cardiology. This procedure offers a minimally invasive means for obtaining important information about the heart and its blood vessels, while also providing a less invasive treatment for certain heart conditions.

2 Feb 2010

Tips to ease prenatal back and neck pain from LSI

One of the most common discomforts experienced by women during pregnancy is back pain. Expectant mothers endure a variety of different types of backache as their hormones and posture change during pregnancy.

2 Feb 2010

Surgeons have a lower preference for back surgery than family doctors

Surgeons are less likely than family physicians or patients to view surgery as the preferred treatment option for low back pain, according to a study in the January 1 issue of Spine.

29 Jan 2010

Back Pain News and Research

Latest Back Pain News and Research

Positive results from Shire's velaglucerase alfa Phase III study for Type 1 Gaucher disease

Sales of Cobroxin exceeds XenaCare Holdings' projections for first 45 days of 2010

Cognitive behavioral therapy effective for insomnia and chronic pain

MHQP: Massachusetts primary care physicians achieve measurable improvements in health care quality

MedX announces the completion of first sale in New Zealand

Acupuncture: An effective pain management therapy for pediatric patients

Doctors do not follow evidence-based guidelines for treating low back pain, says report

Hope for back pain: Minimally invasive facet arthrodesis and spinal cord stimulation

New research may help adopt acupuncture as a treatment option for NHS patients

Results from three phase two studies show the effectiveness of Tanezumab

Recent clinical trials in patients with ALBP show that SOMA 250 mg reduces disability

Study shows Cymbalta reduces chronic low back pain

AMPYRA for MS: Acorda Therapeutics announces wholesale pricing and patient assistance program

One-third of doctors and diabetes patients prioritize health conditions differently

Sales of Nutra Pharma's Cobroxin totaled $583,955 for fourth-quarter ending December 31, 2009

MISI opens new comprehensive spine care facility in Las Colinas

Millennials overly optimistic about their health despite unhealthy habits

Cardiac catheterization: A groundbreaking tool in the field of cardiology

Tips to ease prenatal back and neck pain from LSI

Surgeons have a lower preference for back surgery than family doctors

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Back Pain News and Research

Latest Back Pain News and Research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in